Literature DB >> 25110299

Clinical features and risk factors for development of Bacillus bacteremia among adult patients with cancer: a case-control study.

Jae-Hoon Ko1, Cheol-In Kang, Woo Joo Lee, Kyungmin Huh, Jeong Rae Yoo, Kwangmin Kim, Sun Young Cho, Young Eun Ha, Doo Ryeon Chung, Nam Yong Lee, Kyong Ran Peck, Jae-Hoon Song.   

Abstract

PURPOSE: Bacillus species have been frequently reported in recent decades as true pathogens among cancer patients. The purpose of this study was to evaluate the clinical features and risk factors of Bacillus bacteremia among adult patients with cancer.
METHODS: A case-control study was performed to identify the risk factors of Bacillus bacteremia among adult patients with cancer at a 1,950-bed tertiary care university hospital. Electronic medical records were reviewed for individuals who were diagnosed with Bacillus bacteremia during the period of January 1995 through December 2012. Each case was matched to two controls with cancer and non-Bacillus bacteremia. Logistic regression model was used to identify independent risk factors for Bacillus bacteremia development.
RESULTS: A total of 86 patients with Bacillus bacteremia were included and compared with 172 control patients. The presence of a central venous catheter and use of extended-spectrum cephalosporin within 1 month were identified to be independent risk factors for the development of Bacillus bacteremia. Hospital stays longer than 14 days, a history of hematopoietic stem cell transplantation, and prior use of glycopeptides had a negative association.
CONCLUSIONS: The presence of a central venous catheter and prior use of extended-spectrum cephalosporin within 1 month were independent risk factors for the development of Bacillus bacteremia in adult cancer patients.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25110299     DOI: 10.1007/s00520-014-2382-1

Source DB:  PubMed          Journal:  Support Care Cancer        ISSN: 0941-4355            Impact factor:   3.603


  40 in total

1.  Surveillance of antimicrobial use and antimicrobial resistance in United States hospitals: project ICARE phase 2. Project Intensive Care Antimicrobial Resistance Epidemiology (ICARE) hospitals.

Authors:  S K Fridkin; C D Steward; J R Edwards; E R Pryor; J E McGowan; L K Archibald; R P Gaynes; F C Tenover
Journal:  Clin Infect Dis       Date:  1999-08       Impact factor: 9.079

2.  Serious infections due to "non-pathogenic" organisms of the genus Bacillus. Review of their status as pathogens.

Authors:  W E FARRAR
Journal:  Am J Med       Date:  1963-01       Impact factor: 4.965

3.  Bacillus spp. among hospitalized patients with haematological malignancies: clinical features, epidemics and outcomes.

Authors:  V Ozkocaman; T Ozcelik; R Ali; F Ozkalemkas; A Ozkan; C Ozakin; H Akalin; A Ursavas; F Coskun; B Ener; A Tunali
Journal:  J Hosp Infect       Date:  2006-08-07       Impact factor: 3.926

4.  Cell-wall-deficient bacteria and culture-negative febrile episodes in bone-marrow-transplant recipients.

Authors:  P C Woo; S S Wong; P N Lum; W T Hui; K Y Yuen
Journal:  Lancet       Date:  2001-03-03       Impact factor: 79.321

Review 5.  Bacillus cereus bacteremia and meningitis in immunocompromised children.

Authors:  A H Gaur; C C Patrick; J A McCullers; P M Flynn; T A Pearson; B I Razzouk; S J Thompson; J L Shenep
Journal:  Clin Infect Dis       Date:  2001-04-20       Impact factor: 9.079

6.  Clinical practice guideline for the use of antimicrobial agents in neutropenic patients with cancer: 2010 update by the infectious diseases society of america.

Authors:  Alison G Freifeld; Eric J Bow; Kent A Sepkowitz; Michael J Boeckh; James I Ito; Craig A Mullen; Issam I Raad; Kenneth V Rolston; Jo-Anne H Young; John R Wingard
Journal:  Clin Infect Dis       Date:  2011-02-15       Impact factor: 9.079

7.  A case series of Bacillus cereus septicemia in patients with hematological disease.

Authors:  Yoshihito Uchino; Noriyoshi Iriyama; Ken Matsumoto; Yukio Hirabayashi; Katsuhiro Miura; Daisuke Kurita; Yujin Kobayashi; Mai Yagi; Hitomi Kodaira; Atsuko Hojo; Sumiko Kobayashi; Yoshihiro Hatta; Jin Takeuchi
Journal:  Intern Med       Date:  2012-10-01       Impact factor: 1.271

8.  [Two cases of acute myelogenous leukemia with Bacillus cereus bacteremia resulting in fatal intracranial hemorrhage].

Authors:  H Yoshida; Y Moriyama; T Tatekawa; N Tominaga; H Teshima; A Hiraoka; T Masaoka; T Yoshinaga
Journal:  Rinsho Ketsueki       Date:  1993-12

Review 9.  Bacillus cereus and related species.

Authors:  F A Drobniewski
Journal:  Clin Microbiol Rev       Date:  1993-10       Impact factor: 26.132

10.  Consumption of imipenem correlates with beta-lactam resistance in Pseudomonas aeruginosa.

Authors:  Philipp M Lepper; Eberhard Grusa; Helga Reichl; Josef Högel; Matthias Trautmann
Journal:  Antimicrob Agents Chemother       Date:  2002-09       Impact factor: 5.191

View more
  3 in total

1.  Regarding: Ko JH, et al.: Clinical features and risk factors for development of Bacillus bacteremia among adult patients with cancer: a case-control study. Supp Care Cancer 2015;23(2):377-84.

Authors:  Kenneth Rolston
Journal:  Support Care Cancer       Date:  2015-04-08       Impact factor: 3.603

2.  Clinical characteristics and antimicrobial susceptibility of Bacillus cereus blood stream infections.

Authors:  Mahoko Ikeda; Yuka Yagihara; Keita Tatsuno; Mitsuhiro Okazaki; Shu Okugawa; Kyoji Moriya
Journal:  Ann Clin Microbiol Antimicrob       Date:  2015-09-15       Impact factor: 3.944

3.  Intestinal Flora: A Potential Mechanism by Which Yinlai Decoction Treats Lipopolysaccharide-Induced Pneumonia.

Authors:  Jingnan Xu; Xueyan Ma; Chen Bai; Xin Jiang; Ling Huang; Fei Gao; Yini Li; He Yu; Tiegang Liu; Xiaohong Gu
Journal:  Evid Based Complement Alternat Med       Date:  2022-03-23       Impact factor: 2.629

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.